October 2022
BIOVIC is proud to announce the strategic addition of Growing Ocean International (Singapore) as a valued new shareholder, marking an exciting chapter in our growth and expansion.
In tandem with this development, we are thrilled to designate Jiangsu Biovic Medical Device Co. Ltd. as BIOVIC’s exclusive distributor for the AVATAR® Vascular Graft in China. The Chinese medical device market is one of the world’s fastest-growing sectors, having sustained double-digit growth for over a decade. In 2018, the market reached a remarkable $78.8 billion, a 22% increase over the previous year (www.export.gov).
This partnership with Jiangsu Biovic Medical Device Co. Ltd. positions BIOVIC to leverage this dynamic market, and we are enthusiastically preparing to introduce our innovative products to China, advancing healthcare solutions and solidifying our presence in this pivotal region.
June 2017
BIOVIC proudly announces the commencement of a groundbreaking Post-Market Comparative Clinical Study, designed to evaluate the performance of our flagship product, the AVATAR® ePTFE Vascular Graft, in comparison to competitor ePTFE grafts. This rigorous, randomized, multicenter trial focuses on assessing the patency of the AVATAR® graft when used for dialysis (arteriovenous) access. As the study progresses, clinical data will be meticulously compiled and shared through marketing materials, further solidifying the AVATAR® graft’s position as a leader in vascular solutions and advancing our commitment to innovation and patient care.
June 2015
BIOVIC Sdn Bhd is honored to announce its first equity investment from Innocorp Ventures Sdn Bhd, a distinguished subsidiary of Agensi Inovasi Malaysia (AIM). AIM, a statutory body established to catalyze wealth creation through knowledge, technology, and innovation, plays a pivotal role in fostering Malaysia's innovation ecosystem. By laying the foundation for a new generation of entrepreneurial pioneers, AIM is shaping the future of innovation in the nation.
Innocorp Ventures has recognized the exceptional value BIOVIC contributes to Malaysia’s bioeconomy—not only through our advanced products but also through our cutting-edge technology and intellectual property. With this investment, Innocorp is steadfast in its commitment to supporting BIOVIC’s journey through commercialization and beyond, ensuring our continued growth and success in the global marketplace.
